Skip to main content

Prevalent and Incident Use of SGLT2 Inhibitors

Basic Details
Date Posted
Status
In progress
Medical Product
canagliflozin
canagliflozin/metformin HCl
dapagliflozin propanediol
dapagliflozin/metformin HCl
empagliflozin
empagliflozin/linagliptin
Description

These reports examine the prevalent and incident use of six sodium-glucose cotransporter 2 (SGLT2) inhibitors in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on May 18, 2015 to 14 Data Partners; this report includes information from 14 Data Partners.

Deliverables (1)
Mini-Sentinel Summary Table Report: Prevalent Use of SGLT2 Inhibitors
Additional Details
FDA Center
CDER
Time Period
2013 - 2015
Analysis Type
Descriptive
Data Sources
Mini-Sentinel Distributed Database (MSDD)